Knoll Capital Management as of Sept. 30, 2015
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 19 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medivation | 79.3 | $187M | 4.4M | 42.50 | |
| Ampio Pharmaceuticals | 4.2 | $9.8M | 3.4M | 2.89 | |
| Synthetic Biologics | 3.6 | $8.5M | 3.7M | 2.27 | |
| Alcobra | 2.9 | $6.7M | 1.1M | 6.04 | |
| Abeona Therapeutics | 2.3 | $5.5M | 1.4M | 4.05 | |
| Corbus Pharmaceuticals Hldgs | 1.8 | $4.3M | 2.8M | 1.57 | |
| Newlink Genetics Corporation | 1.6 | $3.7M | 102k | 35.84 | |
| Advaxis | 1.2 | $2.8M | 275k | 10.23 | |
| Bio Blast Pharma | 0.7 | $1.7M | 338k | 5.09 | |
| Caladrius Biosciences | 0.6 | $1.5M | 1.0M | 1.49 | |
| Aldeyra Therapeutics (ALDX) | 0.3 | $792k | 136k | 5.83 | |
| Advaxis Inc. w exp 07/15/201 | 0.3 | $731k | 113k | 6.50 | |
| Keryx Biopharmaceuticals | 0.3 | $704k | 200k | 3.52 | |
| Ohr Pharmaceutical | 0.2 | $566k | 205k | 2.76 | |
| Lion Biotechnologies | 0.2 | $559k | 97k | 5.76 | |
| Galmed Pharmaceuticals | 0.2 | $483k | 65k | 7.43 | |
| Evoke Pharma | 0.1 | $162k | 56k | 2.91 | |
| Zosano Pharma | 0.0 | $74k | 19k | 3.98 | |
| Aptose Biosciences | 0.0 | $51k | 12k | 4.27 |
